IL89894A0 - Single dose intramuscular treatment of chlamydia trachomatis infections - Google Patents

Single dose intramuscular treatment of chlamydia trachomatis infections

Info

Publication number
IL89894A0
IL89894A0 IL89894A IL8989489A IL89894A0 IL 89894 A0 IL89894 A0 IL 89894A0 IL 89894 A IL89894 A IL 89894A IL 8989489 A IL8989489 A IL 8989489A IL 89894 A0 IL89894 A0 IL 89894A0
Authority
IL
Israel
Prior art keywords
single dose
chlamydia trachomatis
trachomatis infections
dose intramuscular
intramuscular treatment
Prior art date
Application number
IL89894A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL89894A0 publication Critical patent/IL89894A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL89894A 1988-04-13 1989-04-10 Single dose intramuscular treatment of chlamydia trachomatis infections IL89894A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18100788A 1988-04-13 1988-04-13

Publications (1)

Publication Number Publication Date
IL89894A0 true IL89894A0 (en) 1989-12-15

Family

ID=22662495

Family Applications (1)

Application Number Title Priority Date Filing Date
IL89894A IL89894A0 (en) 1988-04-13 1989-04-10 Single dose intramuscular treatment of chlamydia trachomatis infections

Country Status (9)

Country Link
EP (1) EP0337733A3 (ja)
JP (1) JPH01305030A (ja)
KR (1) KR890015747A (ja)
AU (1) AU3271589A (ja)
DK (1) DK174589D0 (ja)
FI (1) FI891728A (ja)
IL (1) IL89894A0 (ja)
PT (1) PT90250A (ja)
ZA (1) ZA892667B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6579854B1 (en) 1996-08-14 2003-06-17 Vanderbilt University Diagnosis and management of infection caused by chlamydia
DE69838214T2 (de) * 1997-05-06 2008-05-08 Vanderbilt University, Nashville Zubereitungen von mehreren antichlamydialen mitteln zur diagnose und behandlung von durch chlamydia verursachten infektionen
US6756369B2 (en) 1997-05-06 2004-06-29 Vanderbilt University Diagnosis and management of infection caused by Chlamydia
US6884784B1 (en) 1997-05-06 2005-04-26 Vanderbilt University Diagnosis and management of infection caused by chlamydia
US6664239B2 (en) 1997-05-06 2003-12-16 Vanderbilt University Diagnosis and management of infection caused by Chlamydia
DE102009032298A1 (de) 2009-07-09 2011-01-13 Bergander, Klaus, Dr. Thiol-funktionalisierte copolymere Polyester durch enzymkatalysierte Veresterungsreaktionen
JP6025712B2 (ja) 2010-05-12 2016-11-16 レンペックス・ファーマシューティカルズ・インコーポレイテッド テトラサイクリン組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE786427A (fr) * 1971-07-19 1973-01-18 Pfizer Compositions aqueuses de doxycycline

Also Published As

Publication number Publication date
JPH01305030A (ja) 1989-12-08
EP0337733A3 (en) 1990-01-31
EP0337733A2 (en) 1989-10-18
AU3271589A (en) 1989-10-19
FI891728A (fi) 1989-10-14
ZA892667B (en) 1990-11-28
KR890015747A (ko) 1989-11-25
DK174589D0 (da) 1989-04-12
PT90250A (pt) 1989-11-10
FI891728A0 (fi) 1989-04-12

Similar Documents

Publication Publication Date Title
HU9203626D0 (en) Dipyridamole preparatives for treatment of proliferative deseases
CZ9300230A3 (cs) Kombinační topické prostředky pro léčení bolesti
GB8921123D0 (en) Treatment of ards
GB9208339D0 (en) Treatment composition
GB9215633D0 (en) Novel treatment
GB9222292D0 (en) Treatment of rubber articles
EP0559791A4 (en) Treatment of topical infections
ZA892667B (en) Single dose intramuscular treatment of chlamydia trachomatis infections
GB9203039D0 (en) Treatment
GB9211148D0 (en) Novel treatment
US5011841B1 (en) Treatment of depression
GB2271579B (en) Treatment of wood
GB8709746D0 (en) Chlamydia vaccine
GB9201920D0 (en) Novel treatment i
GB8926171D0 (en) Treatment of infertility
GB9419692D0 (en) Treatment of herpes infections
GB9206442D0 (en) Treatment chamber
AP9300527A0 (en) Novel treatment
GB9203637D0 (en) Novel treatment
GB9021960D0 (en) Treatment of flax
GB9212535D0 (en) Treatment of boimass
GB2260517B (en) Plasma treatment process
AU6726490A (en) Treatment of articles
GB8923206D0 (en) Treatment of flax
GB9117252D0 (en) Treatment of pollution